Coronaviruses.

Severe acute respiratory syndrome coronavirus protein 6 accelerates murine coronavirus infections. J Virol (2006) 1.02

Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol (1995) 1.37

Phenotypic and functional characterization of CD8+ T lymphocytes from the central nervous system of rats with coronavirus JHM induced demyelinating encephalomyelitis. J Neurovirol (1995) 1.07

Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58

Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11

Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00

Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol (1982) 1.62

Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol (1996) 1.57

Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol (1990) 1.57

Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol (1996) 1.46

In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33

Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest (1992) 1.29

Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology (1980) 1.29

Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions. J Virol (1990) 1.25

Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein. Virology (1989) 1.18

Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc Soc Exp Biol Med (1987) 1.16

Coronavirus: a jumping RNA transcription. Cold Spring Harb Symp Quant Biol (1987) 1.15

Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology (1995) 1.14

Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virology (1983) 1.13

RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc Natl Acad Sci U S A (1987) 1.11

Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology (1992) 1.08

Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure. J Virol (1993) 1.06

Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J Virol (1997) 1.06

Contributions of CD8+ T cells and viral spread to demyelinating disease. J Immunol (2000) 1.02

Improvements in obtaining and characterizing mouse cerebrospinal fluid. Application to mouse hepatitis virus-induced encephalomyelitis. J Neuroimmunol (1983) 1.02

Immune mediated clearance of JHM virus from the central nervous system. Adv Exp Med Biol (1987) 0.89

Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure. J Virol (1997) 0.85

RNA recombination of coronavirus. Adv Exp Med Biol (1987) 0.82

Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch Neurol (1987) 0.81

Relapsing encephalomyelitis following transfer of partial immunity to JHM virus. Microb Pathog (1990) 0.80

Viral infections of the nervous system. J Neurosurg (1984) 0.79

Genetic heterogeneity of murine coronaviruses. Arch Virol (1983) 0.79

Case report. Diagnosis of Pick's disease by computed tomography. J Comput Assist Tomogr (1979) 0.79

Quasispecies development by high frequency RNA recombination during MHV persistence. Adv Exp Med Biol (1998) 0.79

Demyelination induced by murine coronavirus JHM infection of congenitally immunodeficient mice. Adv Exp Med Biol (1995) 0.76

Animal models of multiple sclerosis. Mayo Clin Proc (1985) 0.75

Synthesis of immunoglobulin within the central nervous system in multiple sclerosis and other neurological diseases. Detection by analysis of CSF/serum IgG ratio. Am J Clin Pathol (1981) 0.75

Quantitative sense-specific determination of murine coronavirus RNA by reverse transcription polymerase chain reaction. J Virol Methods (1999) 0.75

Coronaviruses and multiple sclerosis. Arch Neurol (1982) 0.75

Fine specificity and genetic restriction of T cell clones specific for mouse hepatitis virus, strain JHM. Adv Exp Med Biol (1984) 0.75

Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'. Mult Scler (2009) 0.75

Cerebrospinal fluid (CSF) immunoglobulin-G(IgC) of extravascular origin in normals and patients with multiple sclerosis (MS): clinical correlation. Trans Am Neurol Assoc (1975) 0.75

Autoimmune disease and viral infection. Prog Brain Res (1983) 0.75

Immunotherapy in multiple sclerosis, Part 1. Am J Health Syst Pharm (1995) 0.75

Immunotherapy in multiple sclerosis, Part 2. Am J Health Syst Pharm (1995) 0.75